These findings highlight the role of TRAF6 in promoting joint destruction and suggest that its inhibition may help restore the balance between osteoclast and osteoblast activity, contributing to disease resolution in RA [28]. The gene discussed is TRAF6; the disease is rheumatoid arthritis.